EUVIMEDEUVIMED entdecken
Multizentrische Studie

Integrating plasma exosomal miRNAs, ultrasound radiomics and tPSA for the diagnosis and prediction of early prostate cancer: a multi-center study

Chao Wang, Chuan Zhou, Yun-Feng Zhang, Han He, Dong Wang, Hao-Xuan Lv, Zhi-Jun Yang, Jia Wang, Yong-Qi Ren, Wen-Bo Zhang, Feng-Hai Zhou

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03682-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Chao Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Lanzhou University, Lanzhou, 73000, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, MicroRNAs, Exosomes, Prostate-Specific Antigen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: The Natural Science Foundation of Gansu Province, Research Fund Project of Internal Medicine Department, Gansu Provincial Hospital, Scientific Research Foundation of Gansu Provincial People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: This multi-center study aims to explore the roles of plasma exosomal microRNAs (miRNAs), ultrasound (US) radiomics, and total prostate-specific antigen (tPSA) levels in early prostate cancer detection. METHODS: We analyzed the publicly available dataset GSE112264 to identify the differentially expressed miRNAs associated with prostate cancer. Then, PyRadiomics was used to extract image features, and least absolute shrinkage and selection operator (LASSO) was used to screen the data. Subsequently, according to strict inclusion and exclusion criteria, the internal dataset (n = 199) was used to construct a diagnostic model, and the receiver operating characteristic (ROC) curve, calibration curve, decision curve analysis (DCA), and DeLong test were used to evaluate its diagnostic performance. Finally, we used an external dataset (n = 158) for further validation. RESULTS: The number of features extracted by PyRadiomics was 851, and the number of features screened by LASSO was 23. We combined the hsa-miR-320c, hsa-miR-944, radiomics, and tPSA features to construct a joint model. The area under the ROC curve of the combined model was 0.935. In the internal validation, the area under the curve (AUC) of the training set was 0.943, and the AUC of the test set was 0.946. The AUC of the external data set was 0.910. The calibration curve and decision curve were consistent with the performance of the combined model. There was a significant difference in the prediction ability between the combined prediction model and the single index prediction model, indicating the high credibility and accuracy of the combined model in predicting PCa. CONCLUSIONS: The combined prediction model, consisting of plasma exosomal miRNAs (hsa-miR-320c and hsa-miR-944), US radiomics, and clinical tPSA, can be utilized for the early diagnosis of prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMicroRNAsExosomesProstate-Specific AntigenHumansMaleUltrasonographyROC CurveBiomarkers, TumorEarly Detection of CancerMiddle AgedAgedRadiomics

Stichwörter der Autor:innen

Early diagnosisMiRNAPlasma exosomesPrediction modelProstate cancer

Substanzen

MicroRNAsProstate-Specific AntigenBiomarkers, Tumor

Autor:innen und Institutionen

  • The First Clinical Medical College of Lanzhou University, Lanzhou, 73000, China.
  • The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, 730000, China.
  • The First Clinical Medical College of Lanzhou University, Lanzhou, 73000, China. ldyy_zhoufh@lzu.edu.cn.
  • Department of Urology, Gansu Provincial Hospital, Lanzhou, 730000, China. ldyy_zhoufh@lzu.edu.cn.

Förderung

  • The Natural Science Foundation of Gansu Province
  • Research Fund Project of Internal Medicine Department, Gansu Provincial Hospital
  • Scientific Research Foundation of Gansu Provincial People's Hospital

Zitieren

APA

Wang, C., Zhou, C., Zhang, Y. F., He, H., Wang, D., Lv, H. X., Yang, Z. J., Wang, J., Ren, Y. Q., Zhang, W. B., & Zhou, F. H. (2024). Integrating plasma exosomal miRNAs, ultrasound radiomics and tPSA for the diagnosis and prediction of early prostate cancer: a multi-center study. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03682-3

Vancouver

Wang C, Zhou C, Zhang YF, He H, Wang D, Lv HX, et al. Integrating plasma exosomal miRNAs, ultrasound radiomics and tPSA for the diagnosis and prediction of early prostate cancer: a multi-center study. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03682-3

BibTeX
@article{Wang2024,
  author = {Wang, Chao and Zhou, Chuan and Zhang, Yun-Feng and He, Han and Wang, Dong and Lv, Hao-Xuan and Yang, Zhi-Jun and Wang, Jia and Ren, Yong-Qi and Zhang, Wen-Bo and Zhou, Feng-Hai},
  title = {Integrating plasma exosomal miRNAs, ultrasound radiomics and tPSA for the diagnosis and prediction of early prostate cancer: a multi-center study},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03682-3}
}
Kostenlos starten →